Journal article · 2025 · Open access
ARTIFICIAL INTELLIGENCE IN DRUG DEVELOPMENT: CURRENT APPLICATIONS, CHALLENGES AND FUTURE PERSPECTIVES
MEDIS – International Journal of Medical Sciences and Research, 4(4), 1–5 · Published 15 December 2025 · DOI 10.35120/medisij040403d
In brief
“ARTIFICIAL INTELLIGENCE IN DRUG DEVELOPMENT: CURRENT APPLICATIONS, CHALLENGES AND FUTURE PERSPECTIVES” is a 2025 journal article by Marija Dimitrovska, published in MEDIS – International Journal of Medical Sciences and Research. OpenAlex counts 0 citations as of 15 November 2026. It is open access under a CC BY-NC licence: the full text is free to read at MEDIS – International Journal of Medical Sciences and Research.
- Citations
- 0
- References
- 10
- Authors
- 1
Abstract
Drug development is a complex, time-consuming, and costly process, with average timelines exceeding a decade and success rates remaining low. Artificial intelligence (AI) has emerged as a transformative tool with the potential to accelerate and optimize every stage of the drug development pipeline. By leveraging vast biomedical datasets, advanced algorithms, and computational power, AI can support target identification, predict molecular properties, design novel compounds, and optimize clinical trial processes. Recent advances in machine learning, deep learning, and natural language processing have demonstrated the ability to uncover patterns and relationships beyond the reach of conventional approaches. AI-driven platforms have already contributed to the discovery of promising therapeutic candidates and facilitated more efficient decision-making. Despite significant progress, challenges remain in data quality, model interpretability, regulatory acceptance, and ethical considerations. This review provides a comprehensive overview of AI methodologies applied to drug discovery and development, highlights notable case studies from academia and industry, and critically examines both the opportunities and limitations of these technologies. We also explore future directions, including integration with complementary technologies, collaborative data sharing models, and evolving regulatory frameworks. By evaluating the current state and potential of AI in pharmaceutical research, this article aims to provide scientists, clinicians, and policymakers with a clear understanding of how AI can be harnessed to transform the drug development landscape.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Dimitrovska, M. (2025). ARTIFICIAL INTELLIGENCE IN DRUG DEVELOPMENT: CURRENT APPLICATIONS, CHALLENGES AND FUTURE PERSPECTIVES. MEDIS – International Journal of Medical Sciences and Research, 4(4), 1–5. https://doi.org/10.35120/medisij040403d
MLA 9
Dimitrovska, Marija. “ARTIFICIAL INTELLIGENCE IN DRUG DEVELOPMENT: CURRENT APPLICATIONS, CHALLENGES AND FUTURE PERSPECTIVES.” MEDIS – International Journal of Medical Sciences and Research, vol. 4, no. 4, 2025, pp. 1–5. https://doi.org/10.35120/medisij040403d.
Chicago
Dimitrovska, Marija. 2025. “ARTIFICIAL INTELLIGENCE IN DRUG DEVELOPMENT: CURRENT APPLICATIONS, CHALLENGES AND FUTURE PERSPECTIVES.” MEDIS – International Journal of Medical Sciences and Research 4 (4): 1–5. https://doi.org/10.35120/medisij040403d.
Harvard
Dimitrovska, M. (2025) ‘ARTIFICIAL INTELLIGENCE IN DRUG DEVELOPMENT: CURRENT APPLICATIONS, CHALLENGES AND FUTURE PERSPECTIVES’, MEDIS – International Journal of Medical Sciences and Research, 4(4), pp. 1–5. doi:10.35120/medisij040403d.
IEEE
M. Dimitrovska, “ARTIFICIAL INTELLIGENCE IN DRUG DEVELOPMENT: CURRENT APPLICATIONS, CHALLENGES AND FUTURE PERSPECTIVES,” MEDIS – International Journal of Medical Sciences and Research, vol. 4, no. 4, pp. 1–5, 2025, doi: 10.35120/medisij040403d.
BibTeX
@article{dimitrovska2025artificial,
title = {{ARTIFICIAL INTELLIGENCE IN DRUG DEVELOPMENT: CURRENT APPLICATIONS, CHALLENGES AND FUTURE PERSPECTIVES}},
author = {Dimitrovska, Marija},
journal = {MEDIS – International Journal of Medical Sciences and Research},
year = {2025},
volume = {4},
number = {4},
pages = {1--5},
doi = {10.35120/medisij040403d},
url = {https://doi.org/10.35120/medisij040403d}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- artificial intelligence
- drug development
- drug discovery
- target identification
- molecular property prediction
- clinical trial optimization
- machine learning
- deep learning
Work with this paper
Most-cited papers in Pharmacology, Toxicology and Pharmaceutics
- AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreadingOleg Trott, Arthur J. Olson · Journal of Computational Chemistry · 2009 · 39,860 citations
- AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibilityGarrett M. Morris, Ruth Huey, William Lindstrom and 4 more · Journal of Computational Chemistry · 2009 · 26,508 citations
- Development and testing of a general amber force fieldJunmei Wang, Romain M. Wolf, James W. Caldwell and 2 more · Journal of Computational Chemistry · 2004 · 20,080 citations
- Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings 1PII of original article: S0169-409X(96)00423-1. The article was originally published in Advanced Drug Delivery Reviews 23 (1997) 3–25. 1Christopher A. Lipinski, Franco Lombardo, Beryl W. Dominy and 1 more · Advanced Drug Delivery Reviews · 2001 · 19,638 citations
- SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small moleculesAntoine Daina, Olivier Alain Michielin, Vincent Zoete · Scientific Reports · 2017 · 19,557 citations
All highly cited Pharmacology, Toxicology and Pharmaceutics papers
Questions about this paper
How do I cite this paper in APA style?
Dimitrovska, M. (2025). ARTIFICIAL INTELLIGENCE IN DRUG DEVELOPMENT: CURRENT APPLICATIONS, CHALLENGES AND FUTURE PERSPECTIVES. MEDIS – International Journal of Medical Sciences and Research, 4(4), 1–5. https://doi.org/10.35120/medisij040403d
How many times has this paper been cited?
0 times, according to OpenAlex on 15 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access: read the free full text at MEDIS – International Journal of Medical Sciences and Research.
Who wrote this paper?
Marija Dimitrovska.
What is the DOI of this paper?
10.35120/medisij040403d. The permanent link is https://doi.org/10.35120/medisij040403d.
Bibliographic data from OpenAlex (CC0), last checked 15 November 2026. ResearchGuru does not host this paper; the links go to the publisher or the repository that does.